The pharmaceutical sector is navigating a challenging landscape, exacerbated by global economic fluctuations. With escalating raw material costs and persistent supply chain issues, drug manufacturers are feeling the financial pinch. This pressure is further intensified by demands from governments, particularly in the US, to keep medication prices in check. Compounding these challenges is the looming threat of numerous patent expirations, which could significantly impact revenue streams for many companies. However, a transformative solution is on the horizon: agentic AI. This innovative technology promises to streamline processes in drug discovery and development, enhance efficiency, and ultimately reduce costs. By harnessing the power of AI, pharmaceutical companies can better manage their operations, address regulatory pressures, and adapt to the evolving market dynamics. As the industry looks to the future, embracing agentic AI could be the key to overcoming current obstacles and ensuring sustainable growth in a highly competitive environment.